Friday, September 23, 2016

Requip


See also: Generic Requip XL


Requip is a brand name of ropinirole, approved by the FDA in the following formulation(s):


REQUIP (ropinirole hydrochloride - tablet; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: September 19, 1997

    Strength(s): EQ 0.25MG BASE [RLD][AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: GLAXOSMITHKLINE

    Approval date: January 27, 1999

    Strength(s): EQ 3MG BASE [AB], EQ 4MG BASE [AB]

Has a generic version of Requip been approved?


Yes. The following products are equivalent to Requip:


ropinirole hydrochloride tablet; oral



  • Manufacturer: ALEMBIC LTD

    Approval date: March 24, 2010

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: APOTEX

    Approval date: February 7, 2012

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: COREPHARMA

    Approval date: May 20, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: February 25, 2010

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: PRINSTON INC

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: PRINSTON INC

    Approval date: July 11, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: ROXANE

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: ROXANE

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: WOCKHARDT

    Approval date: May 29, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: June 1, 2009

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Requip. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Requip.

See also...

  • Requip Consumer Information (Drugs.com)
  • Requip Consumer Information (Wolters Kluwer)
  • Requip Consumer Information (Cerner Multum)
  • Requip Advanced Consumer Information (Micromedex)
  • Requip AHFS DI Monographs (ASHP)
  • Ropinirole Consumer Information (Wolters Kluwer)
  • Ropinirole Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Ropinirole Consumer Information (Cerner Multum)
  • Ropinirole Advanced Consumer Information (Micromedex)
  • Ropinirole Hydrochloride AHFS DI Monographs (ASHP)

No comments:

Post a Comment